Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Nadar

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Sultan Qaboos University Medical Journal|April 19, 2017
New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?Sunil Nadar
Current Pharmaceutical Design|July 23, 2003
The prothrombotic state in hypertension and the effects of antihypertensive treatmentSunil Nadar, Gregory Y H Lip
Expert Opinion on Investigational Drugs|May 25, 2004
Platelet activation in the hypertensive disorders of pregnancySunil Nadar, Gregory Y H Lip
Stroke|August 23, 2003
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain roleSunil Nadar, Gregory Y H Lip
Expert Opinion on Investigational Drugs|November 20, 2002
Ongoing trials involving angiotensin-converting enzyme inhibitorsSunil Nadar, Gregory Y H Lip
The Practitioner|June 21, 2002
Cardiomyopathy in practiceSunil Nadar, Gregory Y H Lip
Journal of the American College of Cardiology|May 28, 2003
Hypertension and the prothrombotic stateSunil Nadar, Gregory Y H Lip
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillationSunil Nadar, Andrew Blann, Gregory Y H Lip
American Journal of Hypertension|September 1, 2006
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patientsSunil Nadar, Andrew D Blann, Gregory Y H Lip
Current Pharmaceutical Design|December 8, 2004
Endothelial dysfunction: methods of assessment and application to hypertensionSunil Nadar, Andrew D Blann, Gregory Y H Lip
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Sultan Qaboos University Medical Journal|April 19, 2017
New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?Sunil Nadar
Current Pharmaceutical Design|July 23, 2003
The prothrombotic state in hypertension and the effects of antihypertensive treatmentSunil Nadar, Gregory Y H Lip
Expert Opinion on Investigational Drugs|May 25, 2004
Platelet activation in the hypertensive disorders of pregnancySunil Nadar, Gregory Y H Lip
Stroke|August 23, 2003
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain roleSunil Nadar, Gregory Y H Lip
Expert Opinion on Investigational Drugs|November 20, 2002
Ongoing trials involving angiotensin-converting enzyme inhibitorsSunil Nadar, Gregory Y H Lip
The Practitioner|June 21, 2002
Cardiomyopathy in practiceSunil Nadar, Gregory Y H Lip
Journal of the American College of Cardiology|May 28, 2003
Hypertension and the prothrombotic stateSunil Nadar, Gregory Y H Lip
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillationSunil Nadar, Andrew Blann, Gregory Y H Lip
American Journal of Hypertension|September 1, 2006
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patientsSunil Nadar, Andrew D Blann, Gregory Y H Lip
Current Pharmaceutical Design|December 8, 2004
Endothelial dysfunction: methods of assessment and application to hypertensionSunil Nadar, Andrew D Blann, Gregory Y H Lip
Pageof 3